Showing 101 - 120 of 150 results
Understanding fine particle pollution
Thirty years of ANSTO's unique capability in monitoring fine particle pollution provides insight on bushfire smoke.
Melbourne Access Proposals
ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.
Gathering international experts to expand the impact of PET imaging
ANSTO expert in molecular imaging contributed to international workshop.
Role at ANSTO
European neutron scattering research community faces challenges
Role at ANSTO
User Meeting 2026 - Awards
You are invited to submit to the various awards from ANSTO and the User Meeting 2026 organising committee.
Advanced Diffraction & Scattering Beamlines (ADS-1 and ADS-2) UNDER CONSTRUCTION
The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.
ASP databases
Datasets from the Aerosol Sampling Program.
Mo-99 Manufacturing Facility
ANSTO's Mo-99 manufacturing facility secures Australia’s ability to produce Mo-99 to meet current and future domestic demand and provide a significant proportion to support global demand.
Running (simulated) rings around cancer
Ultra-realistic simulations of a PET imaging system for next-generation radiotherapy: Collaboration giving back to the open source science community.
Samples - Infrared microspectroscopy
The Infrared microspectroscopy microscopes can record spectra from a range of different samples; from thin microtomed sections to polished blocks and embedded particles. This section highlights the types of samples that can be analysed using the IRM beamline
Research finds a potential new "silver bullet" nanoparticle to treat brain cancer
Collaboration investigates a promising new nanoparticle for potential use in combination with other therapies for brain cancer
Pioneering collaboration advances nuclear medicine
This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.
Role at ANSTO
Shaun Jenkinson is currently Chief Executive Officer of ANSTO.
X-ray fluorescence scanning
X-ray fluorescence scanner is a powerful analytical tool for environmental studies.
Archive
Archive of ANSTO research publications, seminars and short talks.